Phase II trial of BXCL701 and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (EXPEL-PANC).
JOURNAL OF CLINICAL ONCOLOGY（2023）
关键词
metastatic pancreatic ductal adenocarcinoma,pembrolizumab,ductal adenocarcinoma,bxcl701,expel-panc
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要